2024
|
Invention
|
Compositions and methods for viral sensitization.
Provided are compounds that enhance the effica... |
|
Invention
|
Compositions and methods for enhancing production, growth, spread, or oncolytic and immunotherape... |
|
Invention
|
Therapeutic agents for heart failure. Herein are described applications of AZD1152 (Barasertib) o... |
2023
|
Invention
|
Modified orthopoxvirus vectors.
The disclosure relates to modified orthopoxvirus vectors, as wel... |
|
Invention
|
Neddylation-activating enzyme inhibitors as viral sensitizers and uses thereof. The present appli... |
|
Invention
|
Microrna-based compositions and methods used in disease treatment.
The present disclosure provid... |
|
Invention
|
Modulation of satellite cell polarity and asymmetric cell division. The disclosure relates to com... |
2022
|
Invention
|
Method of stimulating asymmetric division of satellite stem cells.
The present disclosure provid... |
|
Invention
|
Constructs for enhanced production of endothelial nitric oxide synthase and methods of producing ... |
|
Invention
|
Viral vaccine. A trivalent transgene that encodes a viral surface glycoprotein component, a viral... |
|
Invention
|
Expression of bacterial dinucleotide cyclases.
A method of constitutively expressing a bacterial... |
|
Invention
|
Expression of bacterial dinucleotide cyclases. A method of constitutively expressing a bacterial ... |
|
Invention
|
Pharmaceutical compositions comprising vanadium salts.
The present application relates to vanadi... |
|
Invention
|
Pharmaceutical compositions comprising vanadium salts. The present application relates to vanadiu... |
|
Invention
|
Extracellular vesicle-directed polypeptide tag.
The present invention is based on the surprising... |
|
Invention
|
Extracellular vesicle-directed polypeptide tag. The present invention is based on the surprising ... |
|
Invention
|
Perioperative innate immune priming in cancer therapy. Therapeutic modalities are provided involv... |
|
Invention
|
Modified vaccinia vectors.
The disclosure relates to modified vaccinia virus vectors derived fro... |
2021
|
Invention
|
Cell-based therapy for viral diseases.
The present application relates to the prevention or trea... |
|
Invention
|
Cell-based therapy for viral diseases. The present application relates to the prevention or treat... |
2020
|
Invention
|
Recombinant polypeptides for programming extracellular vesicles.
Herein is provided a recombinan... |
|
Invention
|
Recombinant polypeptides for programming extracellular vesicles. Herein is provided a recombinant... |
|
Invention
|
Cell-based therapy for the pulmonary system. Cell based therapy comprises administration to the l... |
2019
|
Invention
|
Genetically-engineered mesenchymal stem cells overexpressing aoah and uses thereof.
Genetically-... |
|
Invention
|
Genetically-engineered mesenchymal stem cells overexpressing aoah and uses thereof. Genetically-m... |
|
Invention
|
Treatment of acute myeloid leukemia. Herein are described methods of treating a human subject hav... |
|
Invention
|
Virtual or augmented reality aided 3d visualization and marking system.
There is provided a syst... |
|
Invention
|
Virtual or augmented reality aided 3d visualization and marking system. There is provided a syste... |
|
Invention
|
Microrna-based compositions and methods used in disease treatment. The present disclosure provide... |
|
Invention
|
Adeno-associated virus particle with mutated capsid and methods of use thereof. A recombinant ade... |
|
Invention
|
Modified orthopoxvirus vectors. The disclosure relates to modified orthopoxvirus vectors, as well... |
2018
|
G/S
|
Computer software featuring mathematical algorithms for use in analyzing and predicting health ri... |
2017
|
Invention
|
Compositions and methods for enhancing growth, spread, and oncolytic and immunotherapeutic effica... |
2015
|
G/S
|
Application software, namely, a computer, tablet and mobile device based software application fea... |